TrialClinical and translational science2017

Intravenous Hydroxypropyl β-Cyclodextrin Formulation of Letermovir: A Phase I, Randomized, Single-Ascending, and Multiple-Dose Trial.

K Erb-Zohar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.